Journals / Causapedia / 2020 / Cilt: 9 - Sayı: 3

Castleman Disease

Castleman Hastalığı

Journal
Causapedia
Pages
76–80
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this study, we present a patient who presented with hoarseness and diagnosed as hyaline vascular type Castleman disease.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Castleman disease is a rare benign lymphoproliferative disorder of unknown etiology.
📊
Key Findings & Data:Although, the disease most commonly appears in the mediastinal lymph nodes, it can occur in cervical, retroperitoneal, axillary lymph nodes or in other lymph node regions.
💡
Conclusion & Impact:In this study, we present a patient who presented with hoarseness and diagnosed as hyaline vascular type Castleman disease.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Castleman disease is a rare benign lymphoproliferative disorder of unknown etiology. Although, the disease most commonly appears in the mediastinal lymph nodes, it can occur in cervical, retroperitoneal, axillary lymph nodes or in other lymph node regions. Three histological variants as hyaline-vascular, plasma cell and mix type have been described. Clinically, it is also divided in two types: a localized and systemic types. Localized type is usually asymtomatic and presented as a mass or swelling. Systemic (multicentric) type is characterized with nonspecific symptoms such as fever, anaemia, generalized lymphadenopathy or hepatosplenomegaly. Complete surgical excision is curative for localized type. Although, systemic type is usually treated with radiation therapy, corticosteroids and chemotherapy, there is no certain treatment. In this study, we present a patient who presented with hoarseness and diagnosed as hyaline vascular type Castleman disease.

Özet

Castleman hastalığı ender görülen ve etiyolojisi tam olarak bilinmeyen benign bir lenfoprolifetif hastalıktır. En sık mediastinal lenf nodu tutulumu görülmekle beraber servikal, retroperitoneal, aksiller ve diğer bölgelerdeki lenf nodları da tutulabilir. Histopatolojik olarak hyalin vasküler, plazma hücreli ve miks tip olmak üzere üç tipi bulunmaktadır. Kliniğine göre de lokalize ve sistemik (multisentrik) formları bulunmaktadır. Lokalize tip genellikle asemptomatiktir ve kitle veya şişlik ile kendini gösterir. Sistemik (multisentrik) tipte ise ateş, anemi, yaygın lenfadenopati ve hepatosplenomegali gibi nonspesifik semptomlar görülür. Lokalize tipin tedavisi kitlenin cerrahi eksizyonudur. Sistemik tip tedavisinde genellikle steroid, kemoterapi ve radyoterapi kullanılmasına rağmen kesin tedavisi yoktur. Bu çalışmada ses kısıklığı şikâyeti ile gelen ve hyalin vasküler tip Castleman hastalığı tanısı konulan bir olgu sunuldu.

🔖

Cite This Article

AKDENİZ, H., TOPRAK, N., GÜNDÜZ, A. M., YOKUŞ, A., ARSLAN, H. (2020). Castleman Disease. Causapedia, Cilt: 9 - Sayı: 3, 76–80. https://ajindex.com/articles/157597

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Yaman H, et al. Boyun yerleşimli Castleman Hastalığı. Selçuk Ünv Tıp Derg. 2010;26:153-5
  2. Olak J. Benign lymph node disease involving the mediastinum In: Thomas W Shields, General Thoracic Surgery, 6th Edition. Philadelphia, Lippincott Williams & Wilkins; 2005;2676-81
  3. Castleman B, Iverson L, Menendez VP. Localized mediastinal lymph node hyperplasia resembling thymoma. Cancer. 1956;9:822-30
  4. Gaba AR, et al. Multicentric giant lymph node hyperplasia. Am J Clin Pathol. 1978; 69:86-90
  5. Talat N, Belgaumkar A P, Schulte K M. Surgery in Castleman's disease: a systematic review of 404 published cases. Ann Surg. 2012;255(4):677-84
  6. Parez N, et al. Paediatric Castleman disease: report of seven cases and review of the literature. Eur J Pediatr. 1999; 8: 631-7
  7. Herrada, J., Cabanillas, F., Rice, L., Manning, J., & Pugh, W. (1998). The clinical behavior of localized and multicentric Castleman disease. Ann Intern Med. 1998;128(8):657-62
  8. Burger R, et al. Human herpesvirus type 8 interleukin-6 homologue is functionally active on human myeloma cells. Blood. 1998; 6: 1858-63
  9. Cazorla Jimenez A, et al. Multicenter Castleman disease in AIDS. Its relationship with HHV–8 or herpes virus associated to Kaposi's sarcoma. Study of two cases. Rev Clin Esp. 2005; 12: 607-9
  10. Soumerai J D, Sohani A R, Abramson J S. Diagnosis and management of Castleman disease. Cancer Control. 2014;21(4), 266-78
  11. Bower M, et al. Clinical features and outcome in HIV associated multicentric Castleman's disease. J Clin Oncol. 2011;29(18), 2481-86
  12. Hung IJ, et al. Paraneoplastic syndrome and intrathoracic Castleman disease. Pediatr Blood Cancer. 2006; 5: 616-20
  13. Moon WK, Im JG, Kim JS, et al: Mediastinal Castleman disease: CT findings. J Comput Assist Tomogr 8:43-46, 1994
  14. Dural K, ve ark. Castleman hastalıklı bir olgu. Özyardımcı N, ed. 25.Yıl Akciğer Günleri Kongre Kitabı. 6-10 Mayıs, Bursa. 2000:267-71.